TECH-MAHINDRA
19.9.2023 16:35:36 CEST | Business Wire | Press release
Tech Mahindra, a leading provider of digital transformation, consulting, and business re-engineering services & solutions, today inaugurated a local innovation centre in Espoo, Finland. This expansion comes after a sustained period of growth in the region and signifies Tech Mahindra’s commitment to further its journey in Finland, and the Nordic region. The new centre will accommodate a diverse workforce – increasing the in-country headcount ranging from experienced business leaders to fresh talent, in collaboration with the local ecosystem.
Located in Espoo, a part of the greater Helsinki metropolitan area, the new centre situates Tech Mahindra at the heart of one of the major business hotspots and innovation hubs in the Nordics. From this strategic location, Tech Mahindra will continue to provide digital business transformation services and solutions to customers.
Mohit Joshi, Managing Director and CEO Designate of Tech Mahindra, said, “Given its focus on innovation, sustainability, and a unique approach to entrepreneurship; today Finland ranks amongst the topmost countries in the world that leverage emerging technologies to shape the future business landscape. This is also reflected in Tech Mahindra’s commitment to the ongoing expansion in the Nordics region, and the establishment of our new centre in Espoo. It is our endeavor to widen the talent pool, fuel innovation, improve agility to deliver robust solutions, and be closer to our customers’ businesses to drive sustainable growth.”
The inauguration ceremony was attended by dignitaries such as Raveesh Kumar, Ambassador of India to Finland; Jusa Susia, Senior Director & Head of Region East Asia & India at Business Finland; and Janne Kari, Head of Industry, ICT and Digitalisation at Invest in Finland. Tech Mahindra representatives include CP Gurnani, Managing Director and CEO; Mohit Joshi, Managing Director and CEO Designate; Mukul Dhyani, Senior Vice President & Business Head Continental Europe; Rajesh Barwal, VP & Country Manager for Sweden and Finland; C-H Hallstrom, Vice President, Strategic Programs, Nordics.
Further to the commitment in 2022 to set up a Makers Lab, Tech Mahindra’s research and development arm in Finland, the newly opened centre will also facilitate innovation in collaboration with new and existing customers in the region. The team will work on new and emerging technologies such as Quantum computing, Generative AI and Metaverse. The Makers Lab will also plug into the local startup ecosystem and universities to provide new opportunities in R&D across industries.
In the ten years since Tech Mahindra entered the Finnish market, the organisation has firmly established itself as a leading business transformation expert in the region. By leveraging deep industry expertise and long-term experience in tailoring and deploying best-in-class solutions, Tech Mahindra continues to help businesses to navigate the complex challenges present in the modern business landscape.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919543874/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform for AI-Driven Laboratory Operations5.3.2026 13:30:00 CET | Press release
—Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data —— Learn More from LabVantage Leadership at Pittcon 2026 — LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform. The launch represents a strategic evolution of the company’s laboratory informatics portfolio, integrating advanced AI and smarter automation into the core LabVantage LIMS experience to help laboratories operate with greater accuracy, efficiency, and confidence. LabVantage CORTEX is built to support the growing demand for intelligent, automated laboratory environments across industries, including pharma and biotech, food and beverage, oil and gas, forensics, and more. LabVantage CORTEX provides a customer-centric AI analytics and automation ecosystem t
SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release
SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release
Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a
Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release
Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release
GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom